These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23887035)

  • 1. Use of oral vasopressin V2 receptor antagonist for hyponatremia in acute brain injury.
    Jeon SB; Choi HA; Lesch C; Kim MC; Badjatia N; Claassen J; Mayer SA; Lee K
    Eur Neurol; 2013; 70(3-4):142-8. PubMed ID: 23887035
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to a bolus of conivaptan in patients with acute hyponatremia after brain injury.
    Human T; Onuoha A; Diringer M; Dhar R
    J Crit Care; 2012 Dec; 27(6):745.e1-5. PubMed ID: 22520494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia.
    Schrier RW; Gross P; Gheorghiade M; Berl T; Verbalis JG; Czerwiec FS; Orlandi C;
    N Engl J Med; 2006 Nov; 355(20):2099-112. PubMed ID: 17105757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vasopressin antagonist in hyponatremia. Rapid and simple control of serum sodium concentration].
    MMW Fortschr Med; 2012 Dec; 154(22):78-9. PubMed ID: 23297546
    [No Abstract]   [Full Text] [Related]  

  • 5. Tolvaptan and hyponatremia in a patient with cirrhosis.
    Boyer TD
    Hepatology; 2010 Feb; 51(2):699-702. PubMed ID: 20101750
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of tolvaptan, an oral vasopressin V2 receptor antagonist, in hyponatremia.
    Madias NE
    Am J Kidney Dis; 2007 Aug; 50(2):184-7. PubMed ID: 17660019
    [No Abstract]   [Full Text] [Related]  

  • 7. Tolvaptan for the treatment of hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion.
    Gargani L; Schmidt PH; Gheorghiade M
    Expert Rev Cardiovasc Ther; 2011 Dec; 9(12):1505-13. PubMed ID: 22103869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vasopressin V2-receptor antagonist, tolvaptan, for treatment of heart failure].
    Yamamura Y; Sato O; Fujiki H
    Nihon Rinsho; 2007 May; 65 Suppl 5():164-8. PubMed ID: 17571379
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation and management of hyponatremia: an emerging role for vasopressin receptor antagonists.
    Chen S; Jalandhara N; Batlle D
    Nat Clin Pract Nephrol; 2007 Feb; 3(2):82-95. PubMed ID: 17251996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The therapeutic use of vaptans for the treatment of dilutional hyponatremia.
    Cassagnol M; Shogbon AO; Saad M
    J Pharm Pract; 2011 Aug; 24(4):391-9. PubMed ID: 21813818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaptans and the treatment of water-retaining disorders.
    Quittnat F; Gross P
    Semin Nephrol; 2006 May; 26(3):234-43. PubMed ID: 16713496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind, placebo-controlled, multicenter trial of a vasopressin V2-receptor antagonist in patients with schizophrenia and hyponatremia.
    Josiassen RC; Goldman M; Jessani M; Shaughnessy RA; Albazzaz A; Lee J; Ouyang J; Orlandi C; Czerwiec F
    Biol Psychiatry; 2008 Dec; 64(12):1097-100. PubMed ID: 18692175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyponatremia and the use of vasopressin receptor antagonists in critically ill patients.
    Lehrich RW; Greenberg A
    J Intensive Care Med; 2012; 27(4):207-18. PubMed ID: 21571754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolvaptan (Samsca) for hyponatremia.
    Med Lett Drugs Ther; 2009 Nov; 51(1326):95-6. PubMed ID: 20224525
    [No Abstract]   [Full Text] [Related]  

  • 15. Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis.
    Cárdenas A; Ginès P; Marotta P; Czerwiec F; Oyuang J; Guevara M; Afdhal NH
    J Hepatol; 2012 Mar; 56(3):571-8. PubMed ID: 22027579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aquaretic drugs--a new therapeutic principle in treatment of hyponatremia?].
    Hensen J; Buchfelder M; Gross P
    Fortschr Med; 1997 Jun; 115(17):46-50. PubMed ID: 9312543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Massive aquaresis after tolvaptan administration and albumin infusion in a patient with alcoholic cirrhosis.
    Cho C; Logan JL; Lien YH
    Am J Med; 2012 Jan; 125(1):e5-6. PubMed ID: 22075044
    [No Abstract]   [Full Text] [Related]  

  • 18. Hyponatremia and outcomes in patients with heart failure.
    Goldsmith SR
    Heart; 2012 Dec; 98(24):1761-2. PubMed ID: 23204533
    [No Abstract]   [Full Text] [Related]  

  • 19. SIADH and other hyponatremic disorders: diagnosis and therapeutic problems.
    Saito T
    Nihon Jinzo Gakkai Shi; 1996 Oct; 38(10):429-34. PubMed ID: 8940823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conivaptan Yamanouchi.
    Doggrell SA
    Curr Opin Investig Drugs; 2005 Mar; 6(3):317-26. PubMed ID: 15816509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.